Ionis Pharmaceuticals

$80$125

Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, and rare diseases. Ionis and partner Biogen brought Spinraza to market in 2016 as a treatment for a rare neuromuscular disorder, spinal muscular atrophy.

Report ID:

UMHE21467

Published:

Jan-2022

Pages:

13

Industry:

HeadQuatered Country:

United States

Geography:

Clear
  Get a Free Sample
SKU: UMHE21467 Category:
Scope
Table of content
Companies Mentioned

Scope

“Overview of the company and its product offering
Detailed insight into its Strategy, Vision, Product Portfolio, and Business Headquarter
Information on its recent developments including partnerships, collaborations, and expansions among others
Biography of top management”

You can also purchase parts of this report. Do you want to check out a section wise
price list?

“1. Key Facts of the Company
2. Company Mission, Vision, Value
3. Growth Strategy
4. Key Products & Services offered
5. Other key facts of the company (Infographic)
6. Company History/Timeline
7. Executive Team
8. SWOT Analysis
9. Company Revenue Split
10. Key Financials
11. Recent Development
11.1 Mergers and Acquisitions
11.2 Partnerships

Companies Mentioned

“Bluebird Bio
Arrowhead
Reata
Alnylam”